Strides flagship facility in Bengaluru receives US FDA inspection closure
The company's flagship facility was inspected by the US FDA between December 5 and 9, 2022, and a form 483 listing three inspectional observations was issued
Flagship | 24/02/2023 | By Sudeep Soparkar | 466
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy